Sponsor content

Teva Pharmaceuticals: a leader in CNS specialty medicine

A leader in CNS specialty medicine sales in the United States and in the top five globally, Teva Pharmaceuticals is actively looking to expand its CNS portfolio further. To download the full article, please sign in.

Go to the profile of Teva Pharmaceuticals
Nov 10, 2015
1
Upvote 1
Page of
Go to the profile of Teva Pharmaceuticals

Teva Pharmaceuticals

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products. For more information, visit www.tevapharm.com.

Comments are disabled